Co-founder & CSO of Ranok Therapeutics
Pioneering Chaperone-mediated Protein Degradation (CHAMP) technology to treat cancer and other diseases,
Formerly: FORMA; GSK; Synta; Millennium; ZymoGenetics; Fred Hutch; Northwestern; MSU
Keywords: targeted protein degradation, TPD, PROTAC, biotech, cancer, oncology, Boston, Hangzhou, Shanghai, China
if the data has not been changed, no new rows will appear.
| Day | Followers | Gain | % Gain |
|---|---|---|---|
| September 25, 2023 | 58 | -1 | -1.7% |
| October 22, 2022 | 59 | +1 | +1.8% |
| August 17, 2022 | 58 | +2 | +3.6% |
| July 11, 2022 | 56 | +3 | +5.7% |
| June 04, 2022 | 53 | +4 | +8.2% |